LWAM
BSX icon

Legacy Wealth Asset Management’s Boston Scientific BSX Stock Holding History

Legacy Wealth Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
23,779
+1,668
+8% +$90.6K 0.22% 123
2026
Q1 		$1.39M Buy
22,111
+1,310
+6% +$105K 0.34% 72
2025
Q4 		$1.98M Buy
20,801
+561
+3% +$55K 0.49% 42
2025
Q3 		$1.98M Sell
20,240
-2,226
-10% -$231K 0.48% 44
2025
Q2 		$2.41M Sell
22,466
-659
-3% -$66.7K 0.61% 30
2025
Q1 		$2.33M Sell
23,125
-933
-4% -$93.9K 0.64% 26
2024
Q4 		$2.15M Sell
24,058
-450
-2% -$39.6K 0.58% 33
2024
Q3 		$2.05M Buy
24,508
+472
+2% +$37.2K 0.55% 44
2024
Q2 		$1.85M Buy
24,036
+13,303
+124% +$974K 0.52% 44
2024
Q1 		$735K Hold
10,733
– – 0.2% 141
2023
Q4 		$620K Sell
10,733
-15
-0.1% -$801 0.2% 165
2023
Q3 		$567K Buy
10,748
+54
+0.5% +$2.83K 0.21% 163
2023
Q2 		$578K Sell
10,694
-7,051
-40% -$368K 0.2% 170
2023
Q1 		$888K Sell
17,745
-214
-1% -$10.1K 0.32% 92
2022
Q4 		$831K Sell
17,959
-270
-1% -$11.7K 0.32% 102
2022
Q3 		$706K Sell
18,229
-3,441
-16% -$138K 0.31% 106
2022
Q2 		$808K Buy
21,670
+256
+1% +$10.4K 0.33% 119
2022
Q1 		$948K Buy
21,414
+626
+3% +$27.1K 0.34% 112
2021
Q4 		$883K Buy
20,788
+2,183
+12% +$91.7K 0.3% 130
2021
Q3 		$807K Buy
18,605
+28
+0.2% +$1.24K 0.37% 103
2021
Q2 		$794K Buy
18,577
+633
+4% +$26.6K 0.35% 112
2021
Q1 		$694K Buy
17,944
+427
+2% +$16.2K 0.32% 130
2020
Q4 		$630K Buy
+17,517
New +$631K 0.32% 128

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Legacy Wealth Asset Management's BSX Position: Q2 2026 in Review

Legacy Wealth Asset Management increased its Boston Scientific (BSX) stake by 7.5% in Q2 2026, buying an estimated $90.6K and bringing the position to 23,779 shares worth $1.01M. The position accounts for 0.22% of the portfolio, ranked #123.

Legacy Wealth Asset Management first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.41M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Legacy Wealth Asset Management held 23,779 shares of Boston Scientific worth $1.01M as of Q2 2026.
  • Legacy Wealth Asset Management bought 1,668 Boston Scientific shares in Q2 2026, an estimated $90.6K.
  • Boston Scientific made up 0.22% of Legacy Wealth Asset Management's portfolio in Q2 2026, its #123 holding.
  • Legacy Wealth Asset Management first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
  • Legacy Wealth Asset Management's Boston Scientific position peaked at $2.41M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Legacy Wealth Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.